NO20055891L - Kinazolinderivater som aurorakinaseinhibitorer - Google Patents

Kinazolinderivater som aurorakinaseinhibitorer

Info

Publication number: NO20055891L
Authority: NO; Norway
Prior art keywords: quinazoline derivatives; aurorakinase; inhibitors; treatment; well
Prior art date: 2003-06-17

Application number

NO20055891A

Other languages

English (en)

Norwegian (no)

Inventor

Frederic Henri Jung

Andrew Austen Mortlock

Nicola Murdoch Heron

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-17

Filing date

2005-12-12

Publication date

2006-02-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33522456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20055891(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-12-12 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2006-02-07 Publication of NO20055891L publication Critical patent/NO20055891L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Oncology (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20055891A 2003-06-17 2005-12-12 Kinazolinderivater som aurorakinaseinhibitorer NO20055891L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP03291463		2003-06-17
PCT/GB2004/002564 WO2004113324A1 (fr)	2003-06-17	2004-06-14	Derives de quinazoline tenant lieu d'inhibiteurs de l'aurora kinase

Publications (1)

Publication Number	Publication Date
NO20055891L true NO20055891L (no)	2006-02-07

Family

ID=33522456

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20055891A NO20055891L (no)	2003-06-17	2005-12-12	Kinazolinderivater som aurorakinaseinhibitorer

Country Status (16)

Country	Link
US (1)	US20060178382A1 (fr)
EP (1)	EP1644361A1 (fr)
JP (1)	JP2006527748A (fr)
KR (1)	KR20060011891A (fr)
CN (1)	CN1835945A (fr)
AR (1)	AR045694A1 (fr)
AU (1)	AU2004249477A1 (fr)
BR (1)	BRPI0411503A (fr)
CA (1)	CA2529250A1 (fr)
IL (1)	IL172375A0 (fr)
MX (1)	MXPA05013825A (fr)
NO (1)	NO20055891L (fr)
TW (1)	TW200505452A (fr)
UY (1)	UY28366A1 (fr)
WO (1)	WO2004113324A1 (fr)
ZA (1)	ZA200510257B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1613619B1 (fr) *	2003-04-16	2008-03-26	AstraZeneca AB	Derives de quinazoline pour le traitement du cancer
WO2004105764A1 (fr) *	2003-06-02	2004-12-09	Astrazeneca Ab	Derives de (3-((quinazolin-4-yl) amino)-1h-pyrazol-1-yl) acetamide et composes associes en tant qu'inhibiteurs des kinases aurora pour le traitement de maladies proliferatives telles que le cancer
US7572914B2 (en)	2003-12-19	2009-08-11	Takeda Pharmaceutical Company Limited	Kinase inhibitors
JP2008510734A (ja)	2004-08-18	2008-04-10	タケダサンディエゴインコーポレイテッド	キナーゼ阻害剤
MX2007004403A (es) *	2004-10-12	2007-04-27	Astrazeneca Ab	Derivados de quinazolina.
ATE479687T1 (de)	2004-10-15	2010-09-15	Takeda Pharmaceutical	Kinaseinhibitoren
ES2319462T3 (es) *	2005-03-28	2009-05-07	Bristol-Myers Squibb Company	Inhibidores competitivos de atp cinasas.
US8119655B2 (en)	2005-10-07	2012-02-21	Takeda Pharmaceutical Company Limited	Kinase inhibitors
UY30183A1 (es)	2006-03-02	2007-10-31	Astrazeneca Ab	Derivados de quinolina
JP2009528335A (ja) *	2006-03-02	2009-08-06	アストラゼネカアクチボラグ	キナゾリン誘導体
EP2040711A2 (fr) *	2006-05-18	2009-04-01	Amphora Discovery Corporation	Dérivés de 2-oxo-1,2-dihydroquinoline, compositions pharmaceutiques contenant ces composes, et leurs utilisation en tant qu'agents antiprolifératifs
GB0619342D0 (en) *	2006-09-30	2006-11-08	Vernalis R&D Ltd	New chemical compounds
SG175609A1 (en)	2006-10-09	2011-11-28	Takeda Pharmaceutical	Kinase inhibitors
WO2009114703A2 (fr) *	2008-03-12	2009-09-17	Fox Chase Cancer Center	Thérapie combinée pour le traitement d'un cancer
JP7117323B2 (ja) *	2017-04-27	2022-08-12	アストラゼネカ・アクチエボラーグ	フェノキシキナゾリン化合物及び癌の処置におけるそれらの使用
AU2018259078B2 (en)	2017-04-27	2021-10-07	Astrazeneca Ab	C5-anilinoquinazoline compounds and their use in treating cancer
KR20190043842A (ko)	2017-10-19	2019-04-29	건국대학교 산학협력단	피리미딘-2-아민 유도체, 이의 제조방법 및 이를 포함하는 항암제
CN110372666B (zh) *	2018-04-13	2022-11-08	华东理工大学	喹唑啉类化合物作为egfr三突变抑制剂及其应用
JP7746165B2 (ja) *	2019-02-19	2025-09-30	ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア	Ｎｕｒｒ１受容体調節因子
KR102061458B1 (ko)	2019-08-14	2019-12-31	건국대학교 산학협력단	피리미딘-2-아민 유도체, 이의 제조방법 및 이를 포함하는 항암제
CN112939948B (zh) *	2019-12-11	2022-05-17	苏州美诺医药科技有限公司	新型含喹唑啉类化合物及其中间体与应用
CN113200964B (zh) *	2021-04-25	2022-07-05	南方医科大学南方医院	18f标记的egfr正电子显像剂及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9922171D0 (en) *	1999-09-21	1999-11-17	Zeneca Ltd	Chemical compounds
DE60133897D1 (de) *	2000-06-28	2008-06-19	Astrazeneca Ab	Substituierte chinazolin-derivate und deren verwendung als aurora-2-kinase inhibitoren
US7132427B2 (en) *	2001-06-21	2006-11-07	Ariad Pharmaceuticals, Inc.	Quinazolines and uses thereof
RU2323215C2 (ru) *	2001-12-24	2008-04-27	Астразенека Аб	Замещенные производные хиназолина как ингибиторы ауроракиназы

2004
- 2004-06-07 TW TW093116336A patent/TW200505452A/zh unknown
- 2004-06-14 JP JP2006516425A patent/JP2006527748A/ja active Pending
- 2004-06-14 BR BRPI0411503-1A patent/BRPI0411503A/pt not_active Application Discontinuation
- 2004-06-14 CA CA002529250A patent/CA2529250A1/fr not_active Abandoned
- 2004-06-14 KR KR1020057024207A patent/KR20060011891A/ko not_active Withdrawn
- 2004-06-14 WO PCT/GB2004/002564 patent/WO2004113324A1/fr not_active Ceased
- 2004-06-14 US US10/560,659 patent/US20060178382A1/en not_active Abandoned
- 2004-06-14 MX MXPA05013825A patent/MXPA05013825A/es unknown
- 2004-06-14 CN CNA2004800231405A patent/CN1835945A/zh active Pending
- 2004-06-14 EP EP04736769A patent/EP1644361A1/fr not_active Withdrawn
- 2004-06-14 AU AU2004249477A patent/AU2004249477A1/en not_active Abandoned
- 2004-06-17 AR ARP040102113A patent/AR045694A1/es unknown
- 2004-06-17 UY UY28366A patent/UY28366A1/es not_active Application Discontinuation
2005
- 2005-12-05 IL IL172375A patent/IL172375A0/en unknown
- 2005-12-12 NO NO20055891A patent/NO20055891L/no not_active Application Discontinuation
- 2005-12-15 ZA ZA200510257A patent/ZA200510257B/en unknown

Also Published As

Publication number	Publication date
EP1644361A1 (fr)	2006-04-12
JP2006527748A (ja)	2006-12-07
AU2004249477A1 (en)	2004-12-29
TW200505452A (en)	2005-02-16
BRPI0411503A (pt)	2006-07-25
MXPA05013825A (es)	2006-02-28
KR20060011891A (ko)	2006-02-03
ZA200510257B (en)	2007-05-30
IL172375A0 (en)	2009-02-11
AR045694A1 (es)	2005-11-09
UY28366A1 (es)	2005-01-31
CN1835945A (zh)	2006-09-20
US20060178382A1 (en)	2006-08-10
CA2529250A1 (fr)	2004-12-29
WO2004113324A1 (fr)	2004-12-29

Publication	Publication Date	Title
NO20055891L (no)	2006-02-07	Kinazolinderivater som aurorakinaseinhibitorer
NO20054842L (no)	2005-11-08	Kjemiske forbindelser
DE602004017194D1 (de)	2008-11-27	Pyridylpyrrol-derivate als wirksame kinase-hemmer
DK1636236T3 (da)	2013-12-09	Pyrazolo-quinazolin-derivater, en fremgangsmåde til fremstilling deraf, og deres anvendelse som kinase-inhibitorer
MXPA06000302A (es)	2006-04-18	Derivados de pirazolil-indol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden.
NO20082643L (no)	2008-09-01	Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft
ATE400573T1 (de)	2008-07-15	1h-imidazochinolinderivate als proteinkinaseinhibitoren
NO20030381L (no)	2003-02-24	Bicyklopyrazoler som er aktive som kinaseinhibitorer, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder slikeforbindelser
NO20061506L (no)	2006-06-02	Heterocykliske inhibitorer av MEK og fremgangsmater for anvendelse derav
EA200970595A1 (ru)	2010-02-26	Производные замещенных индазолов, активные в качестве ингибиторов киназ
NO20072259L (no)	2007-06-06	Heteroaryltiazoler og deres anvendelse som P13K-inhibitorer
ATE442142T1 (de)	2009-09-15	Fredericamycin-derivate als arzneimittel zur tumorbehandlung
NO20092737L (no)	2009-09-18	Substituerte pyrazolo-kinazolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som kinase-inhibitorer
NO20085217L (no)	2009-01-12	Effektive pyrimidinderivater i behandlingen av kreft
NO20053775L (no)	2005-09-16	Diazepinoindol derivater som kinaseinhibitorer.
BRPI0413438A (pt)	2006-10-17	derivados de pirimidilpirrol ativos como inibidores de cinase
PA8606201A1 (es)	2005-08-04	DERIVADOS DE PIRROLO[3,4-c) PIRAZOL ACTIVOS COMO INHIBIDORES DE QUINASA, PROCESO PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN
BR0314797A (pt)	2005-07-26	Derivados da pirimidineamida e o uso dos mesmos
NO20063768L (no)	2006-11-02	1H-tieno[2,3c] pyrazolderivater anvendelige som kinaseinhibitorer
NO20073575L (no)	2007-09-13	Farmasoytiske sammensetninger for behandling av cellulitt
TW200502236A (en)	2005-01-16	Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
NO20054360L (no)	2005-10-11	Nye oxazolderivater, deres fremstilling og anvendelse som farmasotiske preparater
DE60214412D1 (de)	2006-10-12	Simplifizierte sarcodictyn-derivate als anti-tumor-mittel

Legal Events

Date	Code	Title	Description
2008-01-21	FC2A	Withdrawal, rejection or dismissal of laid open patent application